Category: Biopharmaceuticals
Biopharmaceuticals market research reports by DIResearch
-
Global Aflibercept Biosimilars Competitive Landscape Professional Research Report 2025
Global Aflibercept Biosimilars Competitive Landscape Professional Research Report 2025 Research Summary Aflibercept biosimilars are biologic medical products highly similar to the original aflibercept (marketed as Eylea), which is an anti-VEGF (vascular endothelial growth factor) therapy used primar ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2025
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2025 Research Summary Biologics are pharmaceutical drugs derived from living organisms, such as proteins, antibodies, or nucleic acids. They are produced using biotechnology processes and are used for the treatment o ... Read More
-
Global Aflibercept Biosimilars Competitive Landscape Professional Research Report 2024
Global Aflibercept Biosimilars Competitive Landscape Professional Research Report 2024 Research Summary Aflibercept biosimilars are biologic medical products highly similar to the original aflibercept (marketed as Eylea), which is an anti-VEGF (vascular endothelial growth factor) therapy used primar ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2024
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2024 Research Summary Biologics are pharmaceutical drugs derived from living organisms, such as proteins, antibodies, or nucleic acids. They are produced using biotechnology processes and are used for the treatment o ... Read More